We would love to hear your thoughts about our site and services, please take our survey here.
Interim Results #HVO
↗️Revenue up 52% = £27.3m
📈EBITDA >doubled = £5.2m
💵Net cash = £31.3m at 30 June
💪FY23 Revenue upgrade = £55m
⬆️ FY23 EBITDA margin upgrade = c.19%
📣Nominal Annual Dividend = details to be announced with FY23 audited results
https://polaris.brighterir.com/public/hvivo/news/rns/story/rgz9g3w
The HVO VP of Regulatory Affairs featured in @pharmafocusasia on how Human Challenge Trials can establish early efficacy for #vaccines & #therapeutics for infectious disease & can be a tool to enhance the success rate for clinical development
(pg 56-59)
https://www.pharmafocusasia.com/latest-ebook
I think maybe you are getting a little confused by Gemfields numbers.
These include beryl in their production figures, and URAH are only referring to gemstone quality material, hence the 3m carats number Vs the 29m carats by Gemfileds.
Hope that helps?
@EncOVac_ is developing a platform for the #encapsulation of vaccines for a wide range of infectious diseases, representing a significant commercial opportunity.
Learn more about the programmes & the strong expertise behind the technology here:
https://www.poolbegpharma.com/pipeline/oral-vaccine-platform/
“…a huge significant additional resource that is classified as JORC exploration target, that is between 166 to 344 million carats, is still in this deposit…”
https://total-market-solutions.com/2023/09/ura-holdings-plc-september-2023/
“…Georgia’s growing economy has generated the surging demand for energy to which BLOE wants to make an ever greater contribution. Georgia continues to forge its own path, developing a liberal economy and democracy with due sensitivity to its geographic and cultural location somewhere between east and west….”
https://total-market-solutions.com/2023/09/block-energy-plc-5/
the #polb ceo runs through the latest slides with ************** on their cutting-edge #ai programmes in #rsv & #influenza
🤖industry leading human challenge trial data powered ai drug discovery
💊successfully identified novel drug targets & treatments
https://www.***************************/poolbeg-pharma-a.i.unlocking-the-power-of-unique-human-challenge-trial-data/4121126617
New research note published by @proactive_UK on #HVO
🏢New Canary Wharf facility
💪Strong H1 Trading
🦠New challenge models
📈Strong position for growth
https://www.proactiveinvestors.co.uk/companies/news/1025502/hvivo-expansion-to-sustain-growth-with-boosted-capacity-1025502.html/long
The #HVO CEO will be presenting at the @masterinvestor #healthcare sector focus webinar on 20 September 2023.
Learn more about #HVO & how they are delivering today’s healthcare by empowering tomorrow’s innovation
Link below :
https://us02web.zoom.us/webinar/register/9116878603180/WN_erJuKCvnRNeiF5D_ngEuWg#/registration
“…We’re coming off the back of two successful wells hoping this is going to be a third…”
https://total-market-solutions.com/2023/08/block-energy-plc-august-2023/
Learn more about the impact of climate change on the spread of #infectiousdisease and how #POLB could make a difference. Explore how climate change reshapes disease dynamics and poses a threat to #globalhealth
https://www.linkedin.com/pulse/impact-climate-change-infectious-diseases-global-health?utm_source=share&utm_medium=member_ios&utm_campaign=share_via
The #HVO CEO spoke with @proactive_UK on yesterdays news, hear more about the new state-of-the-art facility which will open next year to meet the growing demand for their services…
Watch it here: https://youtu.be/15WR4_-BceM?si=K_5-tuSwINbd3whx
HVIVO’s Mo Khan: “From Q2 next year we will have access to 50 quarantine beds, with the potential to expand to a further 70.”
https://www.voxmarkets.co.uk/articles/q-a-with-hvivo-s-ceo-mo-khan-65a101d/